实验室单品
laboratory item
相关产品
CAS:2309010-25-9|Moclobemide-d8
- 产品货号:DT2025061902
- 发布时间:2025-06-06
- 产品CAS :2309010-25-9
- 产品规格:mg(更多包装需求请咨询客服)
- 产品纯度:≥98%
- 产品货期:现货下单后48小时内发货,定制产品4-8周。
- 运输条件:顺丰常规运输
产品详情
货号:DT2025061902
CAS:2309010-25-9
规格:mg(更多包装需求请咨询客服)
纯度:≥98%
生产商:试剂家
生物活性:Moclobemide-d8 (Ro111163-d8) is the deuterium labeled Moclobemide. Moclobemide (Ro111163) is a brain-penetrant and reversible monoamine oxidase (MAO-A) inhibitor with an IC50 of 6.061 μM for hMAO-A[1].Moclobemide up-regulates proliferation of hippocampal progenitor cells in chronically stressed mice.
体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
试剂家 has not independently confirmed the accuracy of these methods. They are for reference only.
Moclobemide-d8 相关抗体:
Monoamine Oxidase A Antibody (YA2036)
Monoamine Oxidase B Antibody (YA2039)
分子量:276.79
Formula:C13H9D8ClN2O2
CAS 号:2309010-25-9
非标记 CAS:71320-77-9
中文名称:吗氯贝胺-d8; 马氯贝胺-d8
运输条件:Room temperature in continental US; may vary elsewhere.
储存方式:Please store the product under the recommended conditions in the Certificate of Analysis.
纯度 & 产品资料
Data Sheet (530 KB)
产品使用指南 (1538 KB)
参考文献
[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.
[Content Brief]
[2]. Nafiz Öncü Can, et al. Synthesis of New Hydrazone Derivatives for MAO Enzymes Inhibitory Activity. Molecules. 2017 Aug 20;22(8):1381.
[Content Brief]
[3]. Yun-feng Li, et al. Moclobemide up-regulates proliferation of hippocampal progenitor cells in chronically stressed mice. Acta Pharmacol Sin. 2004 Nov;25(11):1408-12.
[Content Brief]
在线留言
欢迎您访问“试剂家 | 纳米靶向科研平台”官方网站,请留下您的需求,我们会派专业人员及时与您联系,并为您提供相应的产品方案。